Kevin Tracey, head of the Feinstein Institute for Medical Research, has written in the April Scientific American about the prospects of using the nervous system to stimulate certain biochemical pathways to induce production of molecules that have the same anti-inflammatory effects as a highly targeted drug. Implantation of vagus nerve stimulators or other devices could potentially usher in an era of bioelectronic medicine, as Tracey calls it. Watch Tracey give an overview of his work in a talk from 2011.
Scientific American: An Electrical Off-Switch for Disease
June 26, 2015